According to a recent LinkedIn post from SpinaFX Medical Inc, the company plans to attend the 29th Annual American Society of Spine Radiology Meeting in New Orleans from Feb. 26–28, 2026. The post notes that senior leaders, including the chief medical, strategy, and clinical affairs officers, intend to present insights on the firm’s minimally invasive, image-guided spine therapy.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post also highlights that this therapy has recently received Breakthrough Device designation from the U.S. FDA and references a hands-on workshop scheduled for Feb. 25, 2026. For investors, the presence at a specialized spine radiology meeting and the focus on a breakthrough-designated technology could indicate efforts to build clinical adoption, strengthen key opinion leader support, and position the company for potential future commercialization opportunities in spine-related medtech markets.